The FDA has approved the investigational new drug application of AS1986NS for prostate cancer detection and treatment.
CERo Therapeutics (CERO) announces that the U.S. Food and Drug Administration has cleared the Company’s Investigational New Drug ...
Kennedy has been most vocal about the FDA, an agency that oversees nearly $3 trillion in medicines, food and tobacco products ...
Researchers, public health and health care groups, advocates, industry, and the public must put tackling diet-related disease ...